Lithium Carbonate for Frontotemporal Dementia (Lithium Trial)

"Affirmative. Clinicaltrials.gov details that this experimental trial, which was first introduced on January 27th 2017, is currently enrolling patients. To fulfil the needs of the study, 60 volunteers need to be recruited at two different medical sites."

"Interested participants must be in the range of 40 to 85 years old, as detailed by this study's selection requirements. There are 42 clinical trials available for those under 18 and 436 studies catered towards patients over 65."

"Clinicaltrials.gov states that this medical study is actively enrolling participants, with the first posting on January 27th 2017 and a recent update occurring November 7th 2022."

"Taking into account the Phase 2 trial status, our team at Power assigned Lithium Carbonate a safety rating of 2 out of 3. This is because there are some reports confirming its security but none that suggest it brings about any beneficial effects."

"This medical trial seeks 60 individuals aged between 40 and 85 who are displaying behavioural symptoms. To meet the criteria, they must have a study partner to provide information during interviews, possess Structural MRI or CT scan after symptom onset, be diagnosed with bv-FTD/sv-PPA/nfv-PPA (generally accompanied by behavioural syndrome), score 5 - 26 on Folstein Mini Mental State Examination, exhibit capacity for consent or appoint a surrogate, show moderate to severe NPI agitation/aggression subscale scores higher than 4."